AIMS: The relation between lobular carcinoma in situ (LCIS) and invasive breast cancer is unresolved. In an attempt to establish whether LCIS is a precursor of invasive cancer the mutational status and the expression of E-cadherin was analysed in LCIS and associated invasive breast carcinoma in 23 patients. METHODS: Foci of LCIS and associated invasive carcinoma were individually microdissected from tissue from 23 patients. Exons 4-16 of the E-cadherin gene were analysed using single strand conformation polymorphism (SSCP); protein expression and the localisation of E-cadherin and beta-catenin were assessed with the use of immunohistochemistry. RESULTS: Immunohistochemistry revealed a lack of expression of E-cadherin and beta-catenin in most LCIS samples and invasive foci. In all but four cases, the staining pattern was identical in the LCIS and associated invasive areas. When E-cadherin was absent, beta-catenin was also undetected, suggesting a lack of expression of alternative classic cadherin members in these lesions. Coincident E-cadherin mutations in LCIS and associated invasive carcinoma were not identified in this series of patients. However, mutational analysis of E-cadherin in multiple foci of carcinoma in situ surrounding an invasive lesion provided evidence to support ductal carcinoma in situ as a precursor of invasive ductal carcinoma. CONCLUSION: These data support the hypothesis that LCIS is not a precursor of invasive breast carcinoma but a marker of increased risk of developing invasive disease.
AIMS: The relation between lobular carcinoma in situ (LCIS) and invasive breast cancer is unresolved. In an attempt to establish whether LCIS is a precursor of invasive cancer the mutational status and the expression of E-cadherin was analysed in LCIS and associated invasive breast carcinoma in 23 patients. METHODS: Foci of LCIS and associated invasive carcinoma were individually microdissected from tissue from 23 patients. Exons 4-16 of the E-cadherin gene were analysed using single strand conformation polymorphism (SSCP); protein expression and the localisation of E-cadherin and beta-catenin were assessed with the use of immunohistochemistry. RESULTS: Immunohistochemistry revealed a lack of expression of E-cadherin and beta-catenin in most LCIS samples and invasive foci. In all but four cases, the staining pattern was identical in the LCIS and associated invasive areas. When E-cadherin was absent, beta-catenin was also undetected, suggesting a lack of expression of alternative classic cadherin members in these lesions. Coincident E-cadherin mutations in LCIS and associated invasive carcinoma were not identified in this series of patients. However, mutational analysis of E-cadherin in multiple foci of carcinoma in situ surrounding an invasive lesion provided evidence to support ductal carcinoma in situ as a precursor of invasive ductal carcinoma. CONCLUSION: These data support the hypothesis that LCIS is not a precursor of invasive breast carcinoma but a marker of increased risk of developing invasive disease.
Authors: A M Cleton-Jansen; E W Moerland; N J Kuipers-Dijkshoorn; D F Callen; G R Sutherland; B Hansen; P Devilee; C J Cornelisse Journal: Genes Chromosomes Cancer Date: 1994-02 Impact factor: 5.006
Authors: Stephen J Chanock; Laurie Burdett; Meredith Yeager; Victor Llaca; Anita Langerød; Shafaq Presswalla; Rolf Kaaresen; Robert L Strausberg; Daniela S Gerhard; Vessela Kristensen; Charles M Perou; Anne-Lise Børresen-Dale Journal: Breast Cancer Res Date: 2007 Impact factor: 6.466
Authors: Mary Morrogh; Victor P Andrade; Dilip Giri; Rita A Sakr; Wooyul Paik; Li Xuan Qin; Crispinita D Arroyo; Edi Brogi; Monica Morrow; Tari A King Journal: Breast Cancer Res Treat Date: 2011-11-13 Impact factor: 4.872
Authors: Rita A Sakr; Michail Schizas; Jose V Scarpa Carniello; Charlotte K Y Ng; Salvatore Piscuoglio; Dilip Giri; Victor P Andrade; Marina De Brot; Raymond S Lim; Russell Towers; Britta Weigelt; Jorge S Reis-Filho; Tari A King Journal: Mol Oncol Date: 2015-11-14 Impact factor: 6.603
Authors: Meng Hua Tao; Peter G Shields; Jing Nie; Amy Millen; Christine B Ambrosone; Stephen B Edge; Shiva S Krishnan; Catalin Marian; Bin Xie; Janet Winston; Dominica Vito; Maurizio Trevisan; Jo L Freudenheim Journal: Breast Cancer Res Treat Date: 2008-05-08 Impact factor: 4.872
Authors: Victor P Andrade; Irina Ostrovnaya; Venkatraman E Seshan; Mary Morrogh; Dilip Giri; Narciso Olvera; Marina De Brot; Monica Morrow; Colin B Begg; Tari A King Journal: Breast Cancer Res Date: 2012-07-09 Impact factor: 6.466
Authors: Ya'an Kang; Jianhua Ling; Rei Suzuki; David Roife; Xavier Chopin-Laly; Mark J Truty; Deyali Chatterjee; Huamin Wang; Ryan M Thomas; Matthew H Katz; Paul J Chiao; Jason B Fleming Journal: PLoS One Date: 2014-09-29 Impact factor: 3.240
Authors: Greg J Logan; David J Dabbs; Peter C Lucas; Rachel C Jankowitz; Daniel D Brown; Beth Z Clark; Steffi Oesterreich; Priscilla F McAuliffe Journal: Breast Cancer Res Date: 2015-06-04 Impact factor: 6.466